DaVita Inc. (LON:0I7E)

Market Cap	7.06B -38.2%
Revenue (ttm)	10.14B +6.5%
Net Income	554.87M -20.2%
EPS	7.31 -8.3%
Shares Out	n/a
PE Ratio	12.73
Forward PE	10.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	282
Average Volume	706
Open	145.50
Previous Close	143.93
Day's Range	142.51 - 152.39
52-Week Range	101.01 - 176.92
Beta	1.01
RSI	71.66
Earnings Date	Feb 2, 2026

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1994
• Employees: 76,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I7E

Financial Performance

In 2025, DaVita's revenue was $13.64 billion, an increase of 6.46% compared to the previous year's $12.82 billion. Earnings were $746.80 million, a decrease of -20.24%.

Financial numbers in USD